Erythema Multiforme

Total Page:16

File Type:pdf, Size:1020Kb

Load more

LONDON SATURDAY 8 JANUARY 1972 MEDICAL Br Med J: first published as 10.1136/bmj.1.5792.63 on 8 January 1972. Downloaded from JOURNAL Erythema Multiforme The term erythema multiforme means different things to the names of Stevens and Johnson are correctly attached to different people. Unfortunately the word multiforme is often this syndrome4). Unlike the other types of erythema multi- taken as a licence to apply it to almost any form of erythema forme, in which constitutional upset is usually mild or none, of obscure origin. In some countries even such well-defined this can be a very severe illness, making the patient ex- diseases as pemphigoid have been included. However, there tremely miserable, with high fever and with an appreciable is much to be said for using the diagnosis to describe only mortality rate. Characteristically the mucous membrane of typical cases. It has recently been confirmed' that such the mouth is almost entirely denuded of epithelium and the cases do also have a typical histology distinguishable from eyes show a severe conjunctivitis or corneal damage. Lesions the other types of erythematous eruption. on the genitalia may give rise to retention of urine. Renal Clinically, typical erythema multiforme can occur in disease occurs rarely.5 Bronchitis or pneumonitis, often various forms which differ in the severity of the cell damage, more extensive on x-ray than suspected clinically, is com- so that individual lesions may be macules, papules, or have monly associated. superimposed blisters. The lesions also vary in number The differential diagnosis of the Stevens-Johnson syn- and distribution. Cases showing all types of lesion in any drome includes Behcet's disease, pemphigus, pemphigoid, http://www.bmj.com/ one attack, and cases showing the different clinical pictures and toxic epidermal necrolysis or Lyell's disease. Behqet's in subsequent attacks, leave little doubt that they are all disease should not cause confusion, as it essentially causes basically similar, though it can be argued that the most ulceration of the mouth rather than extensive erosions and severe forms, or Stevens-Johnson syndrome, should be kept is chronic. Pemphigus and pemphigoid are also chronic apart. diseases with characteristic blisters, and any doubts can be The mildest, papular or simplex, form of erythema multi- cleared up by histological examination. Toxic epidermal forme is the commonest. The patient presents with dull necrolysis, with its typical scalded-skin appearance, should on 1 October 2021 by guest. Protected copyright. red maculo-papules up to 2 cm in diameter, often showing not cause confusion, though it was perhaps often classified the characteristic target lesions due to central stagnation or with erythema multiforme before Lyell's description in extravasation of red cells. These tend to have a typical 1956.6 distribution on the backs and fronts of the hands and the The aetiology of all forms of erythema multiforme re- feet and on the extensor aspects of the elbows and knees, mains obscure in most cases. A variety of stimuli have been but may be more widespread. Occasionally they occur on known to trigger it off, with a latent interval of one to three mucous membranes. The differential diagnosis of this type weeks. They include especially virus infections like herpes must include drug eruptions; id eruptions from fungus, simplex and vaccinia, mycoplasma infections, drug sensi- bacterial, or virus infections; and eruptions which are diffi- tivities, pregnancy, and radiotherapy, but the list of re- cult to classify but which in appearance and natural history ported causes is large.78 The most important drugs are seem to be on the borderline between urticaria and erythema barbiturates, long-acting sulphonamides, and phenylbuta- multiforme. One particular type of chilblain with multiple zone.8-11 This all suggests that erythema multiforme is a small lesions on the fingers may closely resemble erythema pattern of reaction based on an immunological mechanism, multiforme.2 Typical erythema multiforme may be asso- though the exact type of this has yet to be demonstrated. ciated with erythema nodosum and then requires the Despite the occasional isolation of viruses or mycoplasmas usual investigations for the latter to exclude tuberculosis, from the blisters,12 it seems unlikely that there is a specific sarcoidosis, and streptococcal and other infections. infective organism. There is no reason to regard these If the inflammatory process is more severe, blisters will patients as being infectious, though they are often best form. Often the lesions are like the papular form, perhaps looked after in isolation for their own protection. only few in number, but with superimposed blisters. In the From the practical point of view erythema multiforme in most severe forms of the disease blistering may be very all its forms is a self-limiting disease over two to six weeks, severe, with extensive mucosal involvement-the so-called and with the exception of drug sensitivities the initiating Stevens-Johnson syndrome3 (there is some doubt whether cause is often no longer active by the time the eruption © BRITISH MEDICAL JOURNAL 1972. AU reproduction rights reserved NO. 5792 PAGE 63 64 BRITISH MEDICAL JOURNAL 8 JANUARY 1972 has appeared. The disease runs much the same course patients believed to be taking prophylaxis conscientiously. whether a cause for it is found or not. The history and Florid rheumatic fever is now relatively rare and also less clinical examination must concentrate on drugs, infections, severe in the more economically advanced nations.4 Though and analysis of any other symptoms. The urine should always this decrease in prevalence and severity began before the Br Med J: first published as 10.1136/bmj.1.5792.63 on 8 January 1972. Downloaded from be examined for protein and red cells. Biopsy is seldom antibiotic era and has probably been associated with altered necessary to establish the diagnosis and does nothing to virulence of the streptococcus and improved social condi- help establish the underlying cause, though immuno- tions, prompt and effective antibiotic therapy in group A fluorescence studies may be helpful in the future. Skin test- streptococcal infections must have further lowered the in- ing has not been shown to be of any value, though occa- cidence. sional positive tests with herpes virus7 and other antigens The changing clinical pattern of rheumatic fever, with have been reported. When drugs are suspected to be caus- minimal or no fever, often a non-migratory monarthritis, ing it they are best avoided in the future irrespective of any arthralgia, abdominal pain, or even carditis as the presenting laboratory investigation. The danger that re-exposure will feature,5 must be appreciated or it may be unrecognized lead to one of the more severe forms of erythema multi- and therefore untreated. A. R. Feinstein6 and Feinstein and forme does not warrant even giving test doses. Serological M. Spagnuolo7 believed that recurrences of rheumatic fever evidence of a preceding infection-for example, myco- tend to repeat the features of the first attack. They claimed plasma-may be found in an appreciable number of cases, that if the first attack did not affect the heart recurrences but by the time the result is available it has usually become were also unlikely to do so, and they suggested that pro- somewhat academic. phylaxis might be reserved for those who develop heart Treatment is essentially symptomatic. The milder forms disease. Perry,3 however, was not so certain, and A. G. Kut- of the disease require little apart from reassurance, and local tner and F. E. Mayer8 noted that 25% of cases did not applications cannot be expected to be much more than follow a repetitive pattern. Nor does that take into account placebos. The ability of systemic steroids to reduce the minimal carditis, which could easily be missed and which mortality of the Stevens-Johnson syndrome has not been could be more severe in a second attack. Though the inci- proved, but there is no doubt that they can sometimes dence of streptococcal infections tends to decrease with age- provide dramatic symptomatic relief, with a starting dose ing the attack rate of rheumatic fever after an infection re- of prednisone 60 mg daily in a severe case. A systemic mains high in the susceptible. antibiotic is often combined to prevent secondary bacterial Spagnuolo, B. Pasternack, and A. Taranta9 recently infection of the denuded area. Probably the most important showed that symptoms of sore throat with fever were part of treatment is skilled nursing. Recovery can be ex- significantly associated with a high recurrence rate-up to pected to be complete, with the possible exception of the in children aged under 12 and 14% in adolescents- more severe ocular complications. 25% recurs, but there is little and particularly so when the interval since the preceding Erythema multiforme sometimes attack of rheumatic fever was short. Those with existing that can be done to prevent recurrences apart from avoid- had had a number ance of offending drugs. Possibly in those cases that follow rheumatic heart disease and those who herpes simplex infection some success may attend early of previous attacks were also particularly susceptible to re- treatment of the herpes with idoxuridine. currences, but there was no significant association between http://www.bmj.com/ recurrence and the rise in the antistreptolysin 0 titre. This Ackerman, A. B., Penneys, N. S., and Clark, W. H., British journal of means that prophylaxis is desirable in all children who have Dermatology, 1971, 84, 554. had rheumatic fever, while it is reasonable to instruct adults ' Haxthausen, H., Cold in Relation to Skin Diseases. Copenhagen, Levin and Munksgaard, 1930. in a first attack without carditis to seek treatment promptly 3 Ashby, D. W., and Lazar, T., Lancet, 1951, 1, 1091.
Recommended publications
  • Dermatology DDX Deck, 2Nd Edition 65

    Dermatology DDX Deck, 2Nd Edition 65

    63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83.
  • Skin Manifestation of SARS-Cov-2: the Italian Experience

    Skin Manifestation of SARS-Cov-2: the Italian Experience

    Journal of Clinical Medicine Article Skin Manifestation of SARS-CoV-2: The Italian Experience Gerardo Cazzato 1 , Caterina Foti 2, Anna Colagrande 1, Antonietta Cimmino 1, Sara Scarcella 1, Gerolamo Cicco 1, Sara Sablone 3, Francesca Arezzo 4, Paolo Romita 2, Teresa Lettini 1 , Leonardo Resta 1 and Giuseppe Ingravallo 1,* 1 Section of Pathology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (G.C.); [email protected] (A.C.); [email protected] (A.C.); [email protected] (S.S.); [email protected] (G.C.); [email protected] (T.L.); [email protected] (L.R.) 2 Section of Dermatology and Venereology, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] (C.F.); [email protected] (P.R.) 3 Section of Forensic Medicine, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] 4 Section of Gynecologic and Obstetrics Clinic, University of Bari ‘Aldo Moro’, 70121 Bari, Italy; [email protected] * Correspondence: [email protected] Abstract: At the end of December 2019, a new coronavirus denominated Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was identified in Wuhan, Hubei province, China. Less than three months later, the World Health Organization (WHO) declared coronavirus disease-19 (COVID-19) to be a global pandemic. Growing numbers of clinical, histopathological, and molecular findings were subsequently reported, among which a particular interest in skin manifestations during the course of the disease was evinced. Today, about one year after the development of the first major infectious foci in Italy, various large case series of patients with COVID-19-related skin Citation: Cazzato, G.; Foti, C.; manifestations have focused on skin specimens.
  • Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting As

    Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting As

    Lepromatous Leprosy with Erythema Nodosum Leprosum Presenting as Chronic Ulcers with Vasculitis: A Case Report and Discussion Anny Xiao, DO,* Erin Lowe, DO,** Richard Miller, DO, FAOCD*** *Traditional Rotating Intern, PGY-1, Largo Medical Center, Largo, FL **Dermatology Resident, PGY-2, Largo Medical Center, Largo, FL ***Program Director, Dermatology Residency, Largo Medical Center, Largo, FL Disclosures: None Correspondence: Anny Xiao, DO; Largo Medical Center, Graduate Medical Education, 201 14th St. SW, Largo, FL 33770; 510-684-4190; [email protected] Abstract Leprosy is a rare, chronic, granulomatous infectious disease with cutaneous and neurologic sequelae. It can be a challenging differential diagnosis in dermatology practice due to several overlapping features with rheumatologic disorders. Patients with leprosy can develop reactive states as a result of immune complex-mediated inflammatory processes, leading to the appearance of additional cutaneous lesions that may further complicate the clinical picture. We describe a case of a woman presenting with a long history of a recurrent bullous rash with chronic ulcers, with an evolution of vasculitic diagnoses, who was later determined to have lepromatous leprosy with reactive erythema nodosum leprosum (ENL). Introduction accompanied by an intense bullous purpuric rash on management of sepsis secondary to bacteremia, Leprosy is a slowly progressive disease caused by bilateral arms and face. For these complaints she was with lower-extremity cellulitis as the suspected infection with Mycobacterium leprae (M. leprae). seen in a Complex Medical Dermatology Clinic and source. A skin biopsy was taken from the left thigh, Spread continues at a steady rate in several endemic clinically diagnosed with cutaneous polyarteritis and histopathology showed epidermal ulceration countries, with more than 200,000 new cases nodosa.
  • Erythema Nodosum (En)

    Erythema Nodosum (En)

    Buffalo Medical Group, P.C. Robert E. Kalb, M.D. Phone: (716) 630-1102 Fax: (716) 633-6507 Department of Dermatology 325 Essjay Road Williamsville, New York 14221 ERYTHEMA NODOSUM (EN) Erythema Nodosum (EN) is a relatively uncommon reaction in the skin consisting of red shiny tender nodular lesions most commonly found on the legs. The erythema refers to the red color that is seen at the surface of the skin. The nodosum refers to the fact that these lesions feel like bumps or nodules underneath the skin surface. Erythema nodosum is a reaction pattern occurring in the subcutaneous tissue and fat. It may be preceded by a low grade fever, fatigue, and joint pains. In about half of the cases, there is an internal condition occurring in the body which contributes to its formation. These include the use of certain medications, certain infections, and a number of other less likely causes. In order to identify cause for the erythema nodosum, it may be necessary to perform blood and laboratory tests. At times, however, the cause cannot be determined and erythema nodosum is considered to be idiopathic in nature. Erythema nodosum often runs an acute course lasting for a brief period from weeks to months. In a small percentage of cases, it can be a more chronic condition. The red nodules are usually confined to the lower legs, but can develop anywhere there is fat under the skin including the thighs, arms, and trunk. Initially, the lesions are more red and inflamed in appearance, but with time become more bruise like.
  • MYELOPATHY ASSOCIATED with SYSTEMIC LUPUS ERYTHEMATOSUS (Erythema Nodosum)

    MYELOPATHY ASSOCIATED with SYSTEMIC LUPUS ERYTHEMATOSUS (Erythema Nodosum)

    Paraplegia 16 (1978-79) 282-294 Original Articles MYELOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS (Erythema Nodosum) L. S. KEWALRAMANI, M.D., M.S.Orth., S. SALEEM, M.D. and D. BERTRAND, M.T. (ASCP) Texas Institute for Rehabilitation and Research and Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, U.S.A. Abstract. Two patients with sudden onset of myelopathy associated with Systemic Lupus Erythematosus (Erythema Nodosum) are described. Pertinent literature is extensively reviewed and these two new patients are added to previously reported 26 patients. Key words: Myelopathy; Meningoencephalomyelopathy; Systemic lupus erythematosus. NEUROLOGICAL manifestations of systemic lupus erythematosus (SLE) have only recently been emphasised although they were mentioned by Kaposi in 1875, who observed stupor and coma as terminal manifestations of the disease. But focal neurological abnormalities were first reported by Osler (1903) and since then there have been several reports in the literature. Most commonly reported entities have been acute organic brain syndrome, seizures and cerebrovascular disorders. Chorea, Guillain Barre syndrome, subarachnoid haemorrhage, peripheral neuro­ pathy and cranial nerve palsies associated with SLE have also been reported on a few occasions. Myelopathy, however, has not received adequate emphasis as a complication of SLE. Fisher and Gilmour reported the first case of flaccid paraplegia in a female with SLE in 1939. Since then only 25 additional cases have been reported in the medical literature over the past 38 years. Twenty cases have been described in sufficient detail and six briefly, to permit a meaningful review of the spinal cord involvement in this disease. We feel that there are probably many more unreported cases of myelopathy associated with SLE.
  • Erythema Marginatum

    Erythema Marginatum

    Figurative Erythemas Michelle Goedken, DO Affiliated Dermatology Scottsdale, AZ Figurative Erythemas • Erythema annulare centrifugum • Erythema marginatum • Erythema migrans • Erythema gyratum repens • Erythema multiforme Erythemas • Erythemas represent a change in the color of the skin that is due to the dilation of blood vessels, especially those in the papillary and reticular dermis • The color is blanchable and most last for days to months • Figurative erythemas have an annular, arciform or polycyclic appearance ERYTHEMA ANNULARE CENTRIFUGUM ERYTHEMA ANNULARE CENTRIFUGUM • Pathogenesis: EAC represents a reaction pattern or hypersensitivity to one of many antigens – IL-2 and TNF-alpha may have a role – Most patients do not have an underlying disease identified ERYTHEMA ANNULARE CENTRIFUGUM • Associated with: – Infection » Dermatophytes and other fungi (Candida and Penicillium in blue cheese) » Viruses: poxvirus, EBV, VZV, HIV » Parasites and ectoparasites – Drugs: diuretics, antimalarials, gold, NSAIDs, finasteride, amitriptyline, etizolam, Ustekinumab (2012) ERYTHEMA ANNULARE CENTRIFUGUM – Foods – Autoimmune endocrinopathies – Neoplasms (lymphomas and leukemias) – Pregnancy – Hypereosinophilic syndrome – Lupus (2014) ERYTHEMA ANNULARE CENTRIFUGUM http://www.dermaamin.com Rongioletti, F., Fausti, V., & Parodi, A ERYTHEMA ANNULARE CENTRIFUGUM • 2 major forms: – Superficial: classic trailing scale, may have associated pruritus – Deep: infiltrated borders, usually no scale, edges are elevated, usually not pruritic ERYTHEMA ANNULARE CENTRIFUGUM
  • Diagnosis, Classification, and Management of Erythema

    Diagnosis, Classification, and Management of Erythema

    Arch Dis Child 2000;83:347–352 347 Diagnosis, classification, and management of Arch Dis Child: first published as 10.1136/adc.83.4.347 on 1 October 2000. Downloaded from erythema multiforme and Stevens–Johnson syndrome C Léauté-Labrèze, T Lamireau, D Chawki, J Maleville, A Taïeb Abstract become widely accepted that EM and SJS, as Background—In adults, erythema multi- well as toxic epidermal necrolysis, are all part of forme (EM) is thought to be mainly a single “EM spectrum”. In both EM and SJS, related to herpes infection and Stevens– pathological changes in the earliest skin lesion Johnson syndrome (SJS) to drug reac- consist of the accumulation of mononuclear tions. cells around the superficial dermal blood Aims—To investigate this hypothesis in vessels; epidermal damage is more characteris- children, and to review our experience in tic of EM with keratinocyte necrosis leading to the management of these patients. multilocular intraepidermal blisters.5 In fact, Methods—A retrospective analysis of 77 there is little clinical resemblance between paediatric cases of EM or SJS admitted to typical EM and SJS, and recently some authors the Children’s Hospital in Bordeaux be- have proposed a reconsideration of the “spec- tween 1974 and 1998. trum” concept and a return to the original Results—Thirty five cases, inadequately description.15–17 According to these authors, the documented or misdiagnosed mostly as term EM should be restricted to acrally urticarias or non-EM drug reactions were distributed typical targets or raised oedema- excluded. Among the remaining 42 pa- tous papules. Depending on the presence or tients (14 girls and 28 boys), 22 had EM (11 absence of mucous membrane erosions the EM minor and 11 EM major), 17 had SJS, cases may be classified as EM major or EM 16 and three had isolated mucous membrane minor.
  • Fundamentals of Dermatology Describing Rashes and Lesions

    Fundamentals of Dermatology Describing Rashes and Lesions

    Dermatology for the Non-Dermatologist May 30 – June 3, 2018 - 1 - Fundamentals of Dermatology Describing Rashes and Lesions History remains ESSENTIAL to establish diagnosis – duration, treatments, prior history of skin conditions, drug use, systemic illness, etc., etc. Historical characteristics of lesions and rashes are also key elements of the description. Painful vs. painless? Pruritic? Burning sensation? Key descriptive elements – 1- definition and morphology of the lesion, 2- location and the extent of the disease. DEFINITIONS: Atrophy: Thinning of the epidermis and/or dermis causing a shiny appearance or fine wrinkling and/or depression of the skin (common causes: steroids, sudden weight gain, “stretch marks”) Bulla: Circumscribed superficial collection of fluid below or within the epidermis > 5mm (if <5mm vesicle), may be formed by the coalescence of vesicles (blister) Burrow: A linear, “threadlike” elevation of the skin, typically a few millimeters long. (scabies) Comedo: A plugged sebaceous follicle, such as closed (whitehead) & open comedones (blackhead) in acne Crust: Dried residue of serum, blood or pus (scab) Cyst: A circumscribed, usually slightly compressible, round, walled lesion, below the epidermis, may be filled with fluid or semi-solid material (sebaceous cyst, cystic acne) Dermatitis: nonspecific term for inflammation of the skin (many possible causes); may be a specific condition, e.g. atopic dermatitis Eczema: a generic term for acute or chronic inflammatory conditions of the skin. Typically appears erythematous,
  • Isotretinoin and the Risk of Erythema Multiforme Final SPC and PL

    Isotretinoin and the Risk of Erythema Multiforme Final SPC and PL

    Isotretinoin and the risk of erythema multiforme Final SPC and PL wording agreed by the PhVWP in June 2010 Doc. Ref.: CMDh/PhVWP/021/2010 Rev 1 July 2010 SUMMARY OF PRODUCT CHARACTERISTICS Section 4.4 There have been post-marketing reports of severe skin reactions (e.g. erythema multiforme (EM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)) associated with isotretinoin use. As these events may be difficult to distinguish from other skin reactions that may occur (see section 4.8), patients should be advised of the signs and symptoms and monitored closely for severe skin reactions. If a severe skin reaction is suspected, isotretinoin treatment should be discontinued. Section 4.8 Skin and subcutaneous tissues Cheilitis, dermatitis, dry skin, localised exfoliation, pruritus, rash disorders: erythematous, skin fragility (risk of frictional trauma) Very common (≥ 1/10) Rare (≥ 1/10 000,< 1/1000) Alopecia Acne fulminans, acne aggravated (acne flare), erythema (facial), exanthema, hair disorders, hirsutism, nail dystrophy, paronychia, Very Rare (≤ 1/10 000) photosensitivity reaction, pyogenic granuloma, skin hyperpigmentation, sweating increased, ∗ Erythema multiforme, Stevens-Johnson Syndrome, toxic Unknown epidermal necrolysis. PACKAGE LEAFLET Possible side effects Skin and hair problems Unknown frequency Serious skin rashes (erythema multiforme, Stevens- Johnson syndrome, and toxic epidermal necrolysis), which are potentially life-threatening and require immediate medical attention. These appear initially as circular patches often with central blisters usually on arms and hands or legs and feet, more severe rashes may include blistering of the chest and back. Additional symptoms such as infection of the eye (conjunctivitis) or ulcers of the mouth, throat or nose may occur.
  • 04Amersoncommondermatoses

    04Amersoncommondermatoses

    Conflicts of Interest None Common Dermatoses in Children & Adults Erin Amerson, MD Department of Dermatology UC San Francisco Outline Impetigo Infections & Infestations Organism 50-70% staphylococcus aureus Remainder group A beta- Skin cancer hemolytic streptococcus or both 2 Forms: Common dermatologic disorders Honey-colored crusts Less common but important diseases Bullous Impetigo- staphylococcus 1 Impetigo Treatment Systemic Abx + topical therapy is best Soak off thick crusts, may use mupirocin oint Beta-lactamase resistant antibiotics x 7 days Dicloxacillin Cephalexin To eradicate nasal Staph carriage Rifampin 600 mg qd X 5 days with your other Abx OR Mupirocin (Bactroban) to nares bid Methicillin Resistant Staph Aureus (MRSA) 40-59% MRSA at UCSF/SFGH Culture for organism and sensitivities Consider if recurrent infection Oral antibiotics that still work: Doxycycline or minocycline Trimethoprim-sulfamethoxazole Clindamycin Can combine any of the above with rifampin Save IV Vanco or Linezolid for MRSA resistant to EVERYTHING 2 Groin Fold Rash DDx Tinea cruris Seborrheic dermatitis Erythrasma Intertrigo Candida Inverse psoriasis Fungal/Yeast Infections of the Groin Tinea Cruris Dermatophyte and Scaly, crusted plaque with central clearing Nystatin not effective Yeast Infections Imidizole/Allylamines x 2-4 weeks as for tinea corporis Candida Moister, more red, satellite pustules Drying agents like Domeboro’s soaks, then Nystatin/Imidizoles 3 Treatment of Onychomycosis Trichophyton rubrum Why treat? Confirm fungal infection before treating DDx: psoriasis, trauma, lichen planus No longer use Griseofulvin: 12-18 months rx & poor efficacy Ketoconazole: risk ↑ LFT’s with long-term use Treatment of Onychomycosis Nail Psoriasis Terbinafine (Lamisil) 250 mg/day x 3-4 months Pulsing being studied Liver toxicity Itraconazole (Sporonox) Pulse at 400 mg/day x 7 days/ mo x 3 months Drug-drug interactions Liver toxicity/CHF/$$$$ 4 Tinea Capitis Tinea Capitis Treatment What to look for: p.o.
  • Drug Eruptions

    Drug Eruptions

    DRUG ERUPTIONS http://www.aocd.org A drug eruption is an adverse skin reaction to a drug. Many medications can cause reactions, especially antimicrobial agents, sulfa drugs, NSAIDs, chemotherapy agents, anticonvulsants, and psychotropic drugs. Drug eruptions can imitate a variety of other skin conditions and therefore should be considered in any patient taking medications or that has changed medications. The onset of drug eruptions is usually within 2 weeks of beginning a new drug or within days if it is due to re-exposure to a certain drug. Itching is the most common symptom. Drug eruptions occur in approximately 2-5% of hospitalized patients and in greater than 1% of the outpatient population. Adverse reactions to drugs are more prevalent in women, in the elderly, and in immunocompromised patients. Drug eruptions may be immunologically or non-immunologically mediated. There are 4 types of immunologically mediated reactions, with Type IV being the most common. Type I is immunoglobulin-E dependent and can result in anaphylaxis, angioedema, and urticaria. Type II is cytotoxic and can result in purpura. Type III reactions are immune complex reactions which can result in vasculitis and type IV is a delayed-type reaction which results in contact dermatitis and photoallergic reactions. This is important as different medications are associated with different types of reactions. For example, insulin is related with type I reactions whereas penicillin, cephalosporins, and sulfonamides cause type II reactions. Quinines and salicylates can cause type III reactions and topical medications such as neomycin can cause type IV reactions. The most common drugs that may potentially cause drug eruptions include amoxicillin, trimethoprim sulfamethoxazole, ampicillin, penicillin, cephalosporins, quinidine and gentamicin sulfate.
  • Oral Diseases Associated with Human Herpes Viruses: Aetiology, Clinical Features, Diagnosis and Management

    Oral Diseases Associated with Human Herpes Viruses: Aetiology, Clinical Features, Diagnosis and Management

    www.sada.co.za / SADJ Vol 71 No. 6 CLINICAL REVIEW < 253 Oral diseases associated with human herpes viruses: aetiology, clinical features, diagnosis and management SADJ July 2016, Vol 71 no 6 p253 - p259 R Ballyram1, NH Wood2, RAG Khammissa3, J Lemmer4, L Feller5 ABSTRACT Human herpesviruses (HHVs) are very prevalent DNA ACRONYMS viruses that can cause a variety of orofacial diseases. EM: erythema multiforme Typically they are highly infectious, are contracted early in HHV: human herpes virus life, and following primary infection, usually persist in a latent form. Primary oral infections are often subclinical, but may PCR: polymerase chain reaction be symptomatic as in the case of herpes simplex virus- HSV, HHV-1: herpes simplex virus induced primary herpetic gingivostomatitis. Reactivation VZV, HHV-3: varicella-zoster virus of the latent forms may result in various conditions: herpes EBV, HHV-4: Epstein-Barr virus simplex virus (HSV) can cause recurrent herpetic orolabial CMV, HHV-5: cytomegalovirus lesions; varicella zoster virus (VZV) can cause herpes zoster; Epstein-Barr virus (EBV) can cause oral hairy Key words: herpes simplex virus, human herpes virus-8, leukoplakia; and reactivation of HHV-8 can cause Kaposi varicella zoster virus, Epstein-Barr virus, recurrent herpes sarcoma. In immunocompromised subjects, infections labialis, recurrent intraoral herpetic ulcers, treatment, val- with human herpesviruses are more extensive and aciclovir, aciclovir, famcicylovir. severe than in immunocompetent subjects. HSV and VZV infections are treated with nucleoside analogues aciclovir, valaciclovir, famciclovir and penciclovir. These agents INTRODucTION have few side effects and are effective when started The human herpesvirus (HHV) family comprises a diverse early in the course of the disease.